What is the Anti-viral Masks market size?

The Anti-viral Masks market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Anti-viral Masks market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Anti-viral Masks market?

Increasing demand for personal protective equipment drives the market.

What are the challenges facing the Anti-viral Masks market?

Supply chain disruptions and raw material shortages are major challenges.

Which regions are leading the Anti-viral Masks market?

North America and Asia Pacific are the leading regions.

Who are the top companies in the Anti-viral Masks market?

Top companies include 3M, Honeywell, and Kimberly-Clark.

What are the future opportunities in the Anti-viral Masks market?

Emerging markets and technological advancements offer future opportunities.

How does technology impact the Anti-viral Masks market?

Advances in filter technology improve mask effectiveness.

What is the regulatory landscape for the Anti-viral Masks market?

Regulations vary by region, with FDA and CE certifications being crucial.

What is the future outlook for the Anti-viral Masks market?

The market is expected to continue growing due to increasing demand.

Anti-viral Masks Market: Opportunity by 2034 | In-Depth Report

Anti-viral Masks by Application (Industrial, Individual, Hospital and Clinic), by Types (Flat-fold, Cup Style), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Anti-viral Masks Market Overview

The Anti-viral Masks market refers to the global market for masks designed to prevent the spread of viral infections. As the world navigates the complexities of pandemic prevention, the Anti-viral Masks market size is estimated to be around $13.4 billion in 2025. The growth outlook for the Anti-viral Masks market appears promising, with a market forecast suggesting significant expansion over the forecast period of 2026-2033. The industry expansion is expected to be driven by a compound annual growth rate (CAGR) of 10.5%, with key drivers including increasing awareness of viral infections, advancements in mask technology, and growing demand from the healthcare and consumer sectors. Key forces shaping the industry include technology shifts towards more effective filtration systems, regulatory requirements for mask standards, and changes in consumer behavior towards health and wellness.

Loading chart…

The largest region for the Anti-viral Masks market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand from countries such as China and India. The market is expected to be shaped by key forces including technology shifts, regulatory requirements, and changes in consumer behavior. As the market continues to evolve, it is likely that we will see significant advancements in mask technology, increased adoption of Anti-viral Masks in various industries, and growing awareness of the importance of viral infection prevention.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	3M; Honeywell; SPRO Medical; KOWA; Makrite; Owens & Minor; Uvex; Kimberly-clark; McKesson; Prestige Ameritech; CM; Molnlycke Health; Moldex-Metric; Ansell; Unicharm; Cardinal Health; Te Yin; Japan Vilene; Shanghai Dasheng; Hakugen; Essity (BSN Medical); Zhende; Winner; Jiangyin Chang-hung; Tamagawa Eizai; Gerson; Suzhou Sanical; Sinotextiles; Alpha Pro Tech; Irema; DACH; Yuanqin; Troge Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Anti-viral Masks market is poised for significant growth, driven by increasing concerns over public health and safety. The global Anti-viral Masks market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in filtration technology have led to the development of more effective Anti-viral Masks, enhancing their appeal to consumers and contributing to the growth of the Anti-viral Masks market.

Government initiatives and regulatory measures aimed at promoting public health and preventing the spread of infectious diseases have increased demand for Anti-viral Masks, driving market growth.

Restraints2 items

High production costs associated with Anti-viral Masks, particularly those with advanced features, may limit their adoption and hinder the growth of the Anti-viral Masks market size.

Competition from alternative products, such as face shields and gowns, may also restrain the growth forecast of the Anti-viral Masks market.

Opportunities2 items

The increasing awareness of the importance of personal protective equipment (PPE) in preventing the spread of infectious diseases presents a significant opportunity for the Anti-viral Masks market to expand its customer base.

The development of sustainable and eco-friendly Anti-viral Masks can help companies differentiate themselves and attract environmentally conscious consumers, contributing to the growth of the Anti-viral Masks market.

Challenges2 items

Ensuring the quality and efficacy of Anti-viral Masks while maintaining affordable prices is a significant challenge that manufacturers must address to sustain growth in the Anti-viral Masks market.

Managing supply chain disruptions and maintaining a stable supply of raw materials is crucial for manufacturers to meet the growing demand for Anti-viral Masks and achieve a positive growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Anti-viral Masks market refers to the various uses of these masks in different settings. This includes personal use, medical use, and industrial use. Each application contributes to the overall Anti-viral Masks market size, with personal use being the largest contributor. The Anti-viral Masks segmentation by application is crucial in understanding the market dynamics and trends. It helps in identifying the most lucrative segments and allocating resources accordingly.

The Types segment of the Anti-viral Masks market is further divided into subtypes, including surgical masks, respirator masks, and cloth masks. Each type has its own unique characteristics, advantages, and disadvantages. Surgical masks, for example, are designed for medical use and offer a high level of protection against viruses. Respirator masks, on the other hand, are designed for personal use and offer a lower level of protection. Understanding the market taxonomy of Anti-viral Masks is essential in making informed decisions and developing effective strategies.

Anti-viral Masks Segmentation Breakdown7 items

Application

Industrial

Individual

Hospital and Clinic

Types

Flat-fold

Cup Style

Regional Insights

Loading chart…

The Anti-viral Masks market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market, driven by key drivers such as high population density, adoption of preventive measures, and significant investments in healthcare infrastructure. The fastest-growing region is expected to be Latin America, driven by increasing awareness of viral diseases, policies supporting public health, and a growing ecosystem of healthcare providers.

In North America, key drivers include high demand for premium masks, advanced infrastructure, and a mature ecosystem of healthcare providers, contributing to a regional forecast of approximately 25% of the global market. Europe is driven by stringent policies regulating mask quality, high adoption rates, and significant investments in research and development, accounting for around 20% of the global market. Middle East & Africa is expected to account for around 15% of the global market, driven by growing awareness of viral diseases, increasing investments in healthcare infrastructure, and a developing ecosystem of healthcare providers.

Competitive Landscape

The Anti-viral Masks market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Anti-viral Masks competitive landscape is characterized by high competition, with key players focusing on differentiation through technology, service models, and channel strength. Global players tend to have an advantage in terms of economies of scale and distribution networks, while local companies often focus on regional expansion and customization.

Common strategies employed by companies in this market include partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To differentiate themselves, companies focus on technology, service models, and cost advantages. The following companies have adopted various strategic focuses:

3M: regional expansion

Honeywell: premium pricing

SPRO Medical: OEM tie-ups

KOWA: local manufacturing

Makrite: innovation pipeline

Owens & Minor: vertical integration

Key Anti-viral Masks Companies33 items

Honeywell

SPRO Medical

KOWA

Makrite

Owens & Minor

Uvex

Kimberly-clark

McKesson

Prestige Ameritech

Molnlycke Health

Moldex-Metric

Ansell

Unicharm

Cardinal Health

Te Yin

Japan Vilene

Shanghai Dasheng

Hakugen

Essity (BSN Medical)

Zhende

Winner

Jiangyin Chang-hung

Tamagawa Eizai

Gerson

Suzhou Sanical

Sinotextiles

Alpha Pro Tech

Irema

DACH

Yuanqin

Troge Medical

Market Ecosystem

The Anti-viral Masks ecosystem encompasses a complex network of participants across the upstream, midstream, and downstream segments. Upstream participants, such as technology providers and raw material suppliers, contribute to the development of Anti-viral Masks. Midstream participants, including OEMs and system integrators, manufacture and integrate the masks. Downstream participants, comprising distributors, channels, and end users, facilitate the distribution and adoption of Anti-viral Masks. The value chain analysis of this ecosystem reveals how value is created and captured across these segments.

Raw material suppliers — provide filter materials

Technology providers — develop anti-viral technologies

OEMs / manufacturers — produce Anti-viral Masks

System integrators / EPCs — integrate mask components

Distributors / channel partners — facilitate mask distribution

Regulators/standards bodies — set mask standards and approvals

End users / buyers — purchase and use Anti-viral Masks

The flow of value within the Anti-viral Masks ecosystem is influenced by control points, such as regulators and standards bodies, which can impact adoption by setting stringent standards and approval processes. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Moreover, switching costs, partnerships, and interoperability requirements may vary across regions, leading to differences in the Anti-viral Masks ecosystem. Understanding these dynamics is essential for navigating the ecosystem and identifying opportunities for growth and collaboration.

Recent Industry Insights

The Anti-viral Masks industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between manufacturers and technology firms have led to the creation of innovative products with enhanced filtration systems. Notable mergers and acquisitions have also taken place, resulting in the expansion of product portfolios and market reach. Furthermore, several companies have launched new products and technologies, such as masks with built-in UV sanitizers and antimicrobial coatings, to cater to the growing demand for effective protective gear.

Regulatory changes, including updated standards for mask efficacy and safety, have driven the adoption of advanced materials and designs in the Anti-viral Masks industry. Additionally, a shift in consumer trends towards prioritizing health and wellness has fueled the growth of the market. Recent funding rounds and expansions have also enabled companies to scale up production and invest in research and development, ultimately shaping the future of the Anti-viral Masks industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Anti-viral Masks market outlook. The market attractiveness is high due to increasing demand for protective gear against viral infections. Competitive intensity is moderate, with several players competing for market share. The long-term outlook is positive, driven by growing awareness of viral diseases and the need for preventive measures.

The innovation landscape is evolving, with companies focusing on developing more effective and comfortable masks. Demand-supply balance is stable, with manufacturers ramping up production to meet growing demand. However, key risk factors include regulatory changes and supply chain disruptions. Overall, the Anti-viral Masks market is expected to experience steady growth, driven by increasing demand and innovation in the industry.

11 items

1. Executive Summary

2. Anti-viral Masks Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Anti-viral Masks Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Anti-viral Masks Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Industrial

6.1.2. Individual

6.1.3. Hospital and Clinic

6.2. Global Anti-viral Masks Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Flat-fold

6.2.2. Cup Style

6.3. Global Anti-viral Masks Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Anti-viral Masks Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Anti-viral Masks Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Anti-viral Masks Market Competition by Key Manufacturers

8.1. Global Anti-viral Masks Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Anti-viral Masks: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 3M

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Honeywell

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. SPRO Medical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. KOWA

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Makrite

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Owens & Minor

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Uvex

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Kimberly-clark

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. McKesson

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Prestige Ameritech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. CM

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Molnlycke Health

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Moldex-Metric

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Ansell

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Unicharm

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Cardinal Health

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Te Yin

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Japan Vilene

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Shanghai Dasheng

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Hakugen

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Essity (BSN Medical)

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Zhende

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Winner

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. Jiangyin Chang-hung

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Tamagawa Eizai

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Gerson

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. Suzhou Sanical

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

9.28. Sinotextiles

9.28.1. Company Basic Information and Sales Area

9.28.2. Main Business/Business Overview

9.28.3. Product Portfolio

9.28.4. Financial

9.28.5. Recent Industry Insights

9.28.6. SWOT Analysis

9.29. Alpha Pro Tech

9.29.1. Company Basic Information and Sales Area

9.29.2. Main Business/Business Overview

9.29.3. Product Portfolio

9.29.4. Financial

9.29.5. Recent Industry Insights

9.29.6. SWOT Analysis

9.30. Irema

9.30.1. Company Basic Information and Sales Area

9.30.2. Main Business/Business Overview

9.30.3. Product Portfolio

9.30.4. Financial

9.30.5. Recent Industry Insights

9.30.6. SWOT Analysis

9.31. DACH

9.31.1. Company Basic Information and Sales Area

9.31.2. Main Business/Business Overview

9.31.3. Product Portfolio

9.31.4. Financial

9.31.5. Recent Industry Insights

9.31.6. SWOT Analysis

9.32. Yuanqin

9.32.1. Company Basic Information and Sales Area

9.32.2. Main Business/Business Overview

9.32.3. Product Portfolio

9.32.4. Financial

9.32.5. Recent Industry Insights

9.32.6. SWOT Analysis

9.33. Troge Medical

9.33.1. Company Basic Information and Sales Area

9.33.2. Main Business/Business Overview

9.33.3. Product Portfolio

9.33.4. Financial

9.33.5. Recent Industry Insights

9.33.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Anti-viral Masks Market

Figure 4: Global Anti-viral Masks Market: Drivers

Figure 5: Global Anti-viral Masks Market: Challenges

Figure 6: Global Anti-viral Masks Market: Trends

Figure 7: Global Anti-viral Masks Market: Opportunity

Figure 8: Global Anti-viral Masks Market: Restraint

Figure 9: Global Anti-viral Masks Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Anti-viral Masks Market Value (USD Million) By Region

Figure 15: Global Anti-viral Masks Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Anti-viral Masks Market Value (USD Million) By Region

Figure 23: Global Anti-viral Masks Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Anti-viral Masks Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Anti-viral Masks Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Anti-viral Masks Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Anti-viral Masks Market Value (USD Million) By Region

Table 10: Global Anti-viral Masks Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Anti-viral Masks Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Anti-viral Masks Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Anti-viral Masks Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: 3M Basic Information And Sales Area

Table 31: 3M. Products Portfolio

Table 32: Honeywell Basic Information And Sales Area

Table 33: Honeywell. Products Portfolio

Table 34: SPRO Medical Basic Information And Sales Area

Table 35: SPRO Medical. Products Portfolio

Table 36: KOWA Basic Information And Sales Area

Table 37: KOWA. Products Portfolio

Table 38: Makrite Basic Information And Sales Area

Table 39: Makrite. Products Portfolio

Table 40: Owens & Minor Basic Information And Sales Area

Table 41: Owens & Minor. Products Portfolio

Table 42: Uvex Basic Information And Sales Area

Table 43: Uvex. Products Portfolio

Table 44: Kimberly-clark Basic Information And Sales Area

Table 45: Kimberly-clark. Products Portfolio

Table 46: McKesson Basic Information And Sales Area

Table 47: McKesson. Products Portfolio

Table 48: Prestige Ameritech Basic Information And Sales Area

Table 49: Prestige Ameritech. Products Portfolio

Table 50: CM Basic Information And Sales Area

Table 51: CM. Products Portfolio

Table 52: Molnlycke Health Basic Information And Sales Area

Table 53: Molnlycke Health. Products Portfolio

Table 54: Moldex-Metric Basic Information And Sales Area

Table 55: Moldex-Metric. Products Portfolio

Table 56: Ansell Basic Information And Sales Area

Table 57: Ansell. Products Portfolio

Table 58: Unicharm Basic Information And Sales Area

Table 59: Unicharm. Products Portfolio

Table 60: Cardinal Health Basic Information And Sales Area

Table 61: Cardinal Health. Products Portfolio

Table 62: Te Yin Basic Information And Sales Area

Table 63: Te Yin. Products Portfolio

Table 64: Japan Vilene Basic Information And Sales Area

Table 65: Japan Vilene. Products Portfolio

Table 66: Shanghai Dasheng Basic Information And Sales Area

Table 67: Shanghai Dasheng. Products Portfolio

Table 68: Hakugen Basic Information And Sales Area

Table 69: Hakugen. Products Portfolio

Table 70: Essity (BSN Medical) Basic Information And Sales Area

Table 71: Essity (BSN Medical). Products Portfolio

Table 72: Zhende Basic Information And Sales Area

Table 73: Zhende. Products Portfolio

Table 74: Winner Basic Information And Sales Area

Table 75: Winner. Products Portfolio

Table 76: Jiangyin Chang-hung Basic Information And Sales Area

Table 77: Jiangyin Chang-hung. Products Portfolio

Table 78: Tamagawa Eizai Basic Information And Sales Area

Table 79: Tamagawa Eizai. Products Portfolio

Table 80: Gerson Basic Information And Sales Area

Table 81: Gerson. Products Portfolio

Table 82: Suzhou Sanical Basic Information And Sales Area

Table 83: Suzhou Sanical. Products Portfolio

Table 84: Sinotextiles Basic Information And Sales Area

Table 85: Sinotextiles. Products Portfolio

Table 86: Alpha Pro Tech Basic Information And Sales Area

Table 87: Alpha Pro Tech. Products Portfolio

Table 88: Irema Basic Information And Sales Area

Table 89: Irema. Products Portfolio

Table 90: DACH Basic Information And Sales Area

Table 91: DACH. Products Portfolio

Table 92: Yuanqin Basic Information And Sales Area

Table 93: Yuanqin. Products Portfolio

Table 94: Troge Medical Basic Information And Sales Area

Table 95: Troge Medical. Products Portfolio

Table 96: Global Market Value (USD Million) (2025-2032) By Application

Table 97: Global Market Share (%) By Application (2032)

Table 98: Global Market Value (USD Million) (2025-2032) By Types

Table 99: Global Market Share (%) By Types (2032)

Table 100: Global Anti-viral Masks Market Value (USD Million) By Region

Table 101: Global Anti-viral Masks Market Share (%) By Region (2025-2032)

Table 102: North America Market Value (USD Million) (2025-2032) By Country

Table 103: North America Market Value (USD Million) (2025-2032) By Application

Table 104: North America Market Value (USD Million) (2025-2032) By Types

Table 105: Europe Market Value (USD Million) (2025-2032) By Country

Table 106: Europe Market Value (USD Million) (2025-2032) By Application

Table 107: Europe Market Value (USD Million) (2025-2032) By Types

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 110: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 111: South America Market Value (USD Million) (2025-2032) By Country

Table 112: South America Market Value (USD Million) (2025-2032) By Application

Table 113: South America Market Value (USD Million) (2025-2032) By Types

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 116: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Anti-viral Masks Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	3M; Honeywell; SPRO Medical; KOWA; Makrite; Owens & Minor; Uvex; Kimberly-clark; McKesson; Prestige Ameritech; CM; Molnlycke Health; Moldex-Metric; Ansell; Unicharm; Cardinal Health; Te Yin; Japan Vilene; Shanghai Dasheng; Hakugen; Essity (BSN Medical); Zhende; Winner; Jiangyin Chang-hung; Tamagawa Eizai; Gerson; Suzhou Sanical; Sinotextiles; Alpha Pro Tech; Irema; DACH; Yuanqin; Troge Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Government initiatives and regulatory measures aimed at promoting public health and preventing the spread of infectious diseases have increased demand for Anti-viral Masks, driving market growth.

Restraints2 items

High production costs associated with Anti-viral Masks, particularly those with advanced features, may limit their adoption and hinder the growth of the Anti-viral Masks market size.

Competition from alternative products, such as face shields and gowns, may also restrain the growth forecast of the Anti-viral Masks market.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Anti-viral Masks Segmentation Breakdown7 items

Application

Industrial

Individual

Hospital and Clinic

Types

Flat-fold

Cup Style

Regional Insights

Loading chart…

Competitive Landscape

3M: regional expansion

Honeywell: premium pricing

SPRO Medical: OEM tie-ups

KOWA: local manufacturing

Makrite: innovation pipeline

Owens & Minor: vertical integration

Key Anti-viral Masks Companies33 items

Honeywell

SPRO Medical

KOWA

Makrite

Owens & Minor

Uvex

Kimberly-clark

McKesson

Prestige Ameritech

Molnlycke Health

Moldex-Metric

Ansell

Unicharm

Cardinal Health

Te Yin

Japan Vilene

Shanghai Dasheng

Hakugen

Essity (BSN Medical)

Zhende

Winner

Jiangyin Chang-hung

Tamagawa Eizai

Gerson

Suzhou Sanical

Sinotextiles

Alpha Pro Tech

Irema

DACH

Yuanqin

Troge Medical

Market Ecosystem

Raw material suppliers — provide filter materials

Technology providers — develop anti-viral technologies

OEMs / manufacturers — produce Anti-viral Masks

System integrators / EPCs — integrate mask components

Distributors / channel partners — facilitate mask distribution

Regulators/standards bodies — set mask standards and approvals

End users / buyers — purchase and use Anti-viral Masks

Recent Industry Insights

Analyst Overview

Table of Contents